Budget Impact Analysis of Afatinib for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 Substitution Mutations in a U.S. Health Plan

Graham, Jonathan, Earnshaw, Stephanie, Burslem, Kate · Journal of Managed Care & Specialty Pharmacy · 2018